Literature DB >> 24802755

Eosinophil granule proteins: form and function.

K Ravi Acharya1, Steven J Ackerman2.   

Abstract

Experimental and clinical data strongly support a role for the eosinophil in the pathogenesis of asthma, allergic and parasitic diseases, and hypereosinophilic syndromes, in addition to more recently identified immunomodulatory roles in shaping innate host defense, adaptive immunity, tissue repair/remodeling, and maintenance of normal tissue homeostasis. A seminal finding was the dependence of allergic airway inflammation on eosinophil-induced recruitment of Th2-polarized effector T-cells to the lung, providing a missing link between these innate immune effectors (eosinophils) and adaptive T-cell responses. Eosinophils come equipped with preformed enzymatic and nonenzymatic cationic proteins, stored in and selectively secreted from their large secondary (specific) granules. These proteins contribute to the functions of the eosinophil in airway inflammation, tissue damage, and remodeling in the asthmatic diathesis. Studies using eosinophil-deficient mouse models, including eosinophil-derived granule protein double knock-out mice (major basic protein-1/eosinophil peroxidase dual gene deletion) show that eosinophils are required for all major hallmarks of asthma pathophysiology: airway epithelial damage and hyperreactivity, and airway remodeling including smooth muscle hyperplasia and subepithelial fibrosis. Here we review key molecular aspects of these eosinophil-derived granule proteins in terms of structure-function relationships to advance understanding of their roles in eosinophil cell biology, molecular biology, and immunobiology in health and disease.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Asthma; Crystal Structure; Enzyme Structure; Eosinophil; Eosinophil Granule Proteins; Inflammation

Mesh:

Substances:

Year:  2014        PMID: 24802755      PMCID: PMC4067173          DOI: 10.1074/jbc.R113.546218

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  99 in total

1.  Activation of rat and human eosinophils by soluble factor(s) released by Schistosoma mansoni Schistosomula.

Authors:  C Auriault; M Capron; A Capron
Journal:  Cell Immunol       Date:  1982-01-01       Impact factor: 4.868

2.  Role for endogenous and acquired peroxidase in the toxoplasmacidal activity of murine and human mononuclear phagocytes.

Authors:  R M Locksley; C B Wilson; S J Klebanoff
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

3.  Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin.

Authors:  S J Ackerman; D A Loegering; P Venge; I Olsson; J B Harley; A S Fauci; G J Gleich
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

4.  Binding of eosinophil peroxidase to mast cell granules with retention of peroxidatic activity.

Authors:  W R Henderson; E C Jong; S J Klebanoff
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

5.  Eosinophil peroxidase-mediated inactivation of leukotrienes B4, C4, and D4.

Authors:  W R Henderson; A Jörg; S J Klebanoff
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

6.  Differences between basophils and mast cells: failure to detect Charcot-Leyden crystal protein (lysophospholipase) and eosinophil granule major basic protein in human mast cells.

Authors:  K M Leiferman; G J Gleich; G M Kephart; H S Haugen; K Hisamatsu; D Proud; L M Lichtenstein; S J Ackerman
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

7.  Biochemical characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase).

Authors:  P F Weller; D S Bach; K F Austen
Journal:  J Biol Chem       Date:  1984-12-25       Impact factor: 5.157

8.  The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X.

Authors:  K Fredens; R Dahl; P Venge
Journal:  J Allergy Clin Immunol       Date:  1982-11       Impact factor: 10.793

9.  Formation of Charcot-Leyden crystals by human basophils.

Authors:  S J Ackerman; G J Weil; G J Gleich
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

10.  Localization of eosinophil granule major basic protein in human basophils.

Authors:  S J Ackerman; G M Kephart; T M Habermann; P R Greipp; G J Gleich
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  146 in total

1.  Toxicity of eosinophil MBP is repressed by intracellular crystallization and promoted by extracellular aggregation.

Authors:  Alice Soragni; Shida Yousefi; Christina Stoeckle; Angela B Soriaga; Michael R Sawaya; Evelyne Kozlowski; Inès Schmid; Susanne Radonjic-Hoesli; Sebastien Boutet; Garth J Williams; Marc Messerschmidt; M Marvin Seibert; Duilio Cascio; Nadia A Zatsepin; Manfred Burghammer; Christian Riekel; Jacques-Philippe Colletier; Roland Riek; David S Eisenberg; Hans-Uwe Simon
Journal:  Mol Cell       Date:  2015-02-26       Impact factor: 17.970

Review 2.  Eosinophilic Skin Diseases: A Comprehensive Review.

Authors:  Hai Long; Guiying Zhang; Ling Wang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

3.  Regulation of Eosinophil Recruitment and Allergic Airway Inflammation by Tropomyosin Receptor Kinase A.

Authors:  Mythili Dileepan; Xiao Na Ge; Idil Bastan; Yana G Greenberg; Yuying Liang; P Sriramarao; Savita P Rao
Journal:  J Immunol       Date:  2019-12-23       Impact factor: 5.422

4.  Peroxidasin and eosinophil peroxidase, but not myeloperoxidase, contribute to renal fibrosis in the murine unilateral ureteral obstruction model.

Authors:  Selene Colon; Haiyan Luan; Yan Liu; Cameron Meyer; Leslie Gewin; Gautam Bhave
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-19

5.  Biomarkers of Physiological Responses to Periods of Intensified, Non-Resistance-Based Exercise Training in Well-Trained Male Athletes: A Systematic Review and Meta-Analysis.

Authors:  Grace Greenham; Jonathan D Buckley; Joel Garrett; Roger Eston; Kevin Norton
Journal:  Sports Med       Date:  2018-11       Impact factor: 11.136

6.  Lactoferrin deficiency induces a pro-metastatic tumor microenvironment through recruiting myeloid-derived suppressor cells in mice.

Authors:  Lingyu Wei; Xuemei Zhang; Jia Wang; Qiurong Ye; Xiang Zheng; Qiu Peng; Ying Zheng; Peishan Liu; Xiaoyue Zhang; Zhengshuo Li; Can Liu; Qun Yan; Guiyuan Li; Jian Ma
Journal:  Oncogene       Date:  2019-08-28       Impact factor: 9.867

7.  Charcot-Leyden crystal protein/galectin-10 is a surrogate biomarker of eosinophilic airway inflammation in asthma.

Authors:  Sharmilee M Nyenhuis; Preeth Alumkal; Jian Du; Brian T Maybruck; Mark Vinicky; Steven J Ackerman
Journal:  Biomark Med       Date:  2019-06-03       Impact factor: 2.851

8.  Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma.

Authors:  Elizabeth A Kelly; Stephane Esnault; Lin Ying Liu; Michael D Evans; Mats W Johansson; Sameer Mathur; Deane F Mosher; Loren C Denlinger; Nizar N Jarjour
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

9.  A Novel RNase 3/ECP Peptide for Pseudomonas aeruginosa Biofilm Eradication That Combines Antimicrobial, Lipopolysaccharide Binding, and Cell-Agglutinating Activities.

Authors:  David Pulido; Guillem Prats-Ejarque; Clara Villalba; Marcel Albacar; Juan J González-López; Marc Torrent; Mohammed Moussaoui; Ester Boix
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

10.  Impact of eosinophil-peroxidase (EPX) deficiency on eosinophil structure and function in mouse airways.

Authors:  Caroline M Percopo; Julia O Krumholz; Elizabeth R Fischer; Laura S Kraemer; Michelle Ma; Karen Laky; Helene F Rosenberg
Journal:  J Leukoc Biol       Date:  2018-10-04       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.